Tumour mutational burden and immune infiltrates in primary renal cell carcinoma and matched brain metastases

被引：0
|
作者：
Steindl, A. [1 ]
Bergen, E. S. [1 ]
Alpar, D. [2 ]
Gatterbauer, B. [3 ]
Dieckmann, K. [4 ]
Widhalm, G. [3 ]
Hainfellner, J. A. [5 ]
Schmidinger, M. [1 ]
Bock, C. [2 ]
Muellauer, L. [6 ]
Preusser, M. [1 ]
Berghoff, A. S. [1 ]
机构：
[1] Med Univ Vienna, Dept Med 1, Vienna, Austria
[2] Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria
[3] Med Univ Vienna, Dept Neurosurg, Vienna, Austria
[4] Med Univ Vienna, Dept Radiotherapy, Vienna, Austria
[5] Med Univ Vienna, Inst Neurol, Vienna, Austria
[6] Med Univ Vienna, Dept Pathol, Vienna, Austria
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
403PD
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Tumor mutational burden and immune infiltrates in renal cell carcinoma and matched brain metastases
    Steindl, A.
    Alpar, D.
    Heller, G.
    Mair, M. J.
    Gatterbauer, B.
    Dieckmann, K.
    Widhalm, G.
    Hainfellner, J. A.
    Schmidinger, M.
    Bock, C.
    Muellauer, L.
    Preusser, M.
    Berghoff, A. S.
    [J]. ESMO OPEN, 2021, 6 (02)
  • [2] Tumour mutational burden and immune-cell infiltration in cervical squamous cell carcinoma
    Yan, Shanquan
    Liu, Dan
    Yang, Xitong
    Wang, Guangming
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2022, 43 (03) : 118 - 126
  • [3] Tumor mutational burden and immune signatures interplay in renal cell carcinoma
    Yakirevich, Evgeny
    Patel, Nimesh R.
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (06)
  • [4] TemozolomideHigh tumour mutational burden in renal cell carcinoma secondary to hypermutation: case report
    [J]. Reactions Weekly, 2020, 1792 (1) : 216 - 216
  • [5] The influence of tumour mutational burden on renal cancer immune infiltration and survival
    Byrne, Matthew H. V.
    Mitchell, Thomas J.
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (06)
  • [6] Exploration of the relationships between tumor mutation burden with immune infiltrates in clear cell renal cell carcinoma
    Zhang, Chuanjie
    Li, Zongtai
    Qi, Feng
    Hu, Xin
    Luo, Jun
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (22)
  • [7] MTOR PATHWAY ACTIVATION IN PRIMARY RENAL CELL CARCINOMA (RCC) AND MATCHED METASTASES
    Kutikov, Alexander
    Egleston, Brian L.
    Morrison, Tasha
    Henske, Elizabeth P.
    Huang, Min
    Al-Saleem, Tahseen
    Uzzo, Robert G.
    [J]. JOURNAL OF UROLOGY, 2009, 181 (04): : 500 - 500
  • [8] Tumour immune microenvironment in primary and metastatic papillary renal cell carcinoma
    Eich, Marie-Lisa
    Chaux, Alcides
    Rodriguez, Maria Angelica Mendoza
    Guner, Gunes
    Taheri, Diana
    Pena, Maria Del Carmen Rodriguez
    Sharma, Rajni
    Allaf, Mohamad E.
    Netto, George J.
    [J]. HISTOPATHOLOGY, 2020, 76 (03) : 423 - 432
  • [9] Actionable mutations and mutational burden in renal cell carcinoma
    Mockus, Susan M.
    Patterson, Sara E.
    Pettus, Jason R.
    Tsongalis, Gregory J.
    [J]. CANCER RESEARCH, 2016, 76
  • [10] Immune cell infiltrates and prognosis in primary carcinoma of the lung
    Johnson, SK
    Kerr, KM
    Chapman, AD
    Kennedy, MM
    King, G
    Cockburn, JS
    Jeffrey, RR
    [J]. LUNG CANCER, 2000, 27 (01) : 27 - 35
12345